Valbenazine in Elderly Adults with Tardive Dyskinesia
June 3, 2025
The use of antipsychotics in geriatric patients is complicated by t...
Read More
Long-Acting Injectable Antipsychotics in the Geriatric Population
August 9, 2024
The use of antipsychotics in geriatric patients is complicated by t...
Read More
NEI Podcast: Episode 225 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Agitation with Dr. Leslie Citrome
May 22, 2024
How do symptoms of agitation manifest differently in disorders such...
Read More
Erectile Dysfunction Drugs May Protect Against Alzheimer’s
March 3, 2024
With Alzheimer’s disease (AD) cases projected to reach 157 million ...
Read More
Optimizing Treatment For Older Adults With Depression
January 4, 2024
Depression in older adults presents distinct difficulties due to it...
Read More
Physical Activity and Depression in Older Adults
July 24, 2023
A recent study investigated the most common causes of hospitalizati...
Read More
Sleep-Disordered Breathing Tied to Brain Volumes in Amyloid-Positive Older Adults
June 19, 2023
Sleep-disordered breathing (SDB) has been associated with increased...
Read More
FDA Approves First Treatment for Agitation Associated with Alzheimer’s Dementia
May 10, 2023
The U.S. Food and Drug Administration (FDA) has approved the supple...
Read More
Blood Test Predicts Which People With Amyloid Are Likely to Decline Cognitively
March 1, 2023
The pathology of Alzheimer’s disease (AD) begins with a prolonged p...
Read More
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
January 23, 2023
The U.S. Food and Drug Administration recently approved lecanemab, ...
Read More
'Convincing Evidence' Hearing Aids Reduce Dementia Risk
December 20, 2022
With no truly effective treatment for dementia yet available, there...
Read More
FDA Panel Rejects Pimavanserin for Alzheimer's Psychosis
June 21, 2022
A U.S. Food and Drug Administration advisory panel voted 9:3 agains...
Read More